MOTS-c Results Timeline
What the standard MOTS-c research protocol looks like phase by phase, over a typical 4–8 weeks on, then equal break cycle. This is the escalation schedule from our full dosing protocol, presented as a timeline rather than a table.
Quick Facts
Phase-by-Phase Timeline
Weeks 1–2
Target dose: 500 mcg (0.5 mg)
Weeks 3–4
Target dose: 1000 mcg (1.0 mg)
Weeks 5–6
Target dose: 1500 mcg (1.5 mg)
Weeks 7–8
Target dose: 2000 mcg (2.0 mg)
Reported in Research
- ✓4–8 weeks on, followed by 4–8 weeks off.
This timeline reflects the structure of the standard MOTS-c research protocol documented on this site — it is not a guarantee of individual outcomes, and timelines vary between research subjects. All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.